ILD Clinical Trials

1,710 recruitingLast updated: June 18, 2026

There are 1,710 actively recruiting ild clinical trials across 98 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Toronto, Ontario, Canada. Updated daily from ClinicalTrials.gov.


ILD Trials at a Glance

1,710 actively recruiting trials for ild are listed on ClinicalTrialsFinder across 6 cities in 98 countries. The largest study group is Not Applicable with 870 trials, with the heaviest enrollment activity in New York, Boston, and Toronto. Lead sponsors running ild studies include Riphah International University, Johns Hopkins University, and University of California, San Francisco.

Treatments under study

About ILD Clinical Trials

Looking for clinical trials for ILD? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ILD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ILD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,710 trials

Recruiting
Phase 1

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

HealthyMild Cognitive ImpairmentAlzheimer s Disease
National Institute of Mental Health (NIMH)90 enrolled1 locationNCT07169630
Recruiting
Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

DementiaALSMild Cognitive Impairment+2 more
National Institute of Mental Health (NIMH)184 enrolled1 locationNCT04396873
Recruiting
Phase 1Phase 2

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Brain CancerGBMGlioma+12 more
National Institute of Neurological Disorders and Stroke (NINDS)40 enrolled1 locationNCT07416188
Recruiting
Phase 1

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

PineoblastomaEmbryonal Tumor With Multilayered RosettesEpendymoma+3 more
Children's National Research Institute12 enrolled1 locationNCT06193759
Recruiting

Early Detection of Advanced Adenomas and Colorectal Cancer

Colorectal, CancerColorectal NeoplasmsColorectal Adenocarcinoma+15 more
City of Hope Medical Center2,000 enrolled6 locationsNCT06342440
Recruiting
Not Applicable

The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma

Glioblastoma (GBM)IDH Wildtype Glioblastoma
Ottawa Hospital Research Institute50 enrolled2 locationsNCT06850766
Recruiting
Not Applicable

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

DementiaMild Cognitive Impairment (MCI)Potentially Inappropriate Medication Use
Johns Hopkins University100 enrolled1 locationNCT07454824
Recruiting
Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia

InsomniaAcute Lymphoblastic Leukemia ALLSurvivor of Childhood Cancer
St. Jude Children's Research Hospital40 enrolled1 locationNCT07191119
Recruiting

Protocol For Collecting Data On Patients With Childhood Cancer

Childhood Cancer
St. Jude Children's Research Hospital30,000 enrolled1 locationNCT00684580
Recruiting
Not Applicable

Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial

Chronic PainChildhood Cancer Survivor
St. Jude Children's Research Hospital228 enrolled1 locationNCT07160621
Recruiting

Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure

Lyme DiseaseChronic Lyme DiseasePregnancy Complications+3 more
Children's National Research Institute40 enrolled1 locationNCT06026969
Recruiting
Phase 2

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

Sleep DisturbanceAMCI - Amnestic Mild Cognitive Impairment
Johns Hopkins University100 enrolled1 locationNCT05282550
Recruiting
Not Applicable

Sensory Optimization of the Hospital Environment

Development, InfantParentsPreterm+2 more
University of Southern California215 enrolled1 locationNCT05230199
Recruiting
Not Applicable

Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study

Depressive DisorderPercutaneous Coronary Intervention (PCI)Acute Coronary Syndrome (ACS)+5 more
Jing Han120 enrolled1 locationNCT07454070
Recruiting
Early Phase 1

Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma

Recurrent Glioblastoma, IDH-WildtypeGlioblastoma (GBM)Recurrent Glioblastoma+1 more
Beijing Tiantan Hospital5 enrolled2 locationsNCT07648823
Recruiting
Phase 2

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Mild Neurocognitive DisorderMajor Depressive DisorderHIV
National Institute of Allergy and Infectious Diseases (NIAID)186 enrolled41 locationsNCT06705478
Recruiting
Phase 2

Phentermine's Impact on Treatment in Teens

Childhood Obesity
Russell McCulloh, MD240 enrolled2 locationsNCT07282340
Recruiting
Not Applicable

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Childhood Cancer
Washington University School of Medicine146 enrolled1 locationNCT05582551
Recruiting
Not Applicable

rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression

Depressive SymptomsMild Cognitive Impairment (MCI)
Cheng-Hsin General Hospital45 enrolled1 locationNCT07652775
Recruiting
Phase 1Phase 2

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III
Debiopharm International SA116 enrolled16 locationsNCT05765812